IBDEI057 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6618,1,4,0)
 ;;=4^V42.2
 ;;^UTILITY(U,$J,358.3,6618,1,5,0)
 ;;=5^Heart Valve Transplant
 ;;^UTILITY(U,$J,358.3,6618,2)
 ;;=^295437
 ;;^UTILITY(U,$J,358.3,6619,0)
 ;;=V45.01^^43^443^4
 ;;^UTILITY(U,$J,358.3,6619,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6619,1,4,0)
 ;;=4^V45.01
 ;;^UTILITY(U,$J,358.3,6619,1,5,0)
 ;;=5^Pacemaker Status
 ;;^UTILITY(U,$J,358.3,6619,2)
 ;;=^303419
 ;;^UTILITY(U,$J,358.3,6620,0)
 ;;=584.9^^43^444^4
 ;;^UTILITY(U,$J,358.3,6620,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6620,1,4,0)
 ;;=4^584.9
 ;;^UTILITY(U,$J,358.3,6620,1,5,0)
 ;;=5^Acute Renal Failure NOS
 ;;^UTILITY(U,$J,358.3,6620,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,6621,0)
 ;;=584.7^^43^444^1
 ;;^UTILITY(U,$J,358.3,6621,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6621,1,4,0)
 ;;=4^584.7
 ;;^UTILITY(U,$J,358.3,6621,1,5,0)
 ;;=5^AC Ren Fail w/Lesion Medull Necr
 ;;^UTILITY(U,$J,358.3,6621,2)
 ;;=^338530
 ;;^UTILITY(U,$J,358.3,6622,0)
 ;;=584.6^^43^444^3
 ;;^UTILITY(U,$J,358.3,6622,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6622,1,4,0)
 ;;=4^584.6
 ;;^UTILITY(U,$J,358.3,6622,1,5,0)
 ;;=5^AC Renal Fail w/Lesion of Renal Cort
 ;;^UTILITY(U,$J,358.3,6622,2)
 ;;=^338529
 ;;^UTILITY(U,$J,358.3,6623,0)
 ;;=584.6^^43^444^2
 ;;^UTILITY(U,$J,358.3,6623,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6623,1,4,0)
 ;;=4^584.6
 ;;^UTILITY(U,$J,358.3,6623,1,5,0)
 ;;=5^AC Renal Fail w/Lesion Tubular Necro
 ;;^UTILITY(U,$J,358.3,6623,2)
 ;;=^338529
 ;;^UTILITY(U,$J,358.3,6624,0)
 ;;=585.6^^43^445^6
 ;;^UTILITY(U,$J,358.3,6624,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6624,1,4,0)
 ;;=4^585.6
 ;;^UTILITY(U,$J,358.3,6624,1,5,0)
 ;;=5^End Stage Renal Disease
 ;;^UTILITY(U,$J,358.3,6624,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,6625,0)
 ;;=586.^^43^445^7
 ;;^UTILITY(U,$J,358.3,6625,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6625,1,4,0)
 ;;=4^586.
 ;;^UTILITY(U,$J,358.3,6625,1,5,0)
 ;;=5^Renal Failure NOS
 ;;^UTILITY(U,$J,358.3,6625,2)
 ;;=^104733
 ;;^UTILITY(U,$J,358.3,6626,0)
 ;;=585.1^^43^445^1
 ;;^UTILITY(U,$J,358.3,6626,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6626,1,4,0)
 ;;=4^585.1
 ;;^UTILITY(U,$J,358.3,6626,1,5,0)
 ;;=5^CHR Kid Dis,Stage I
 ;;^UTILITY(U,$J,358.3,6626,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,6627,0)
 ;;=585.2^^43^445^2
 ;;^UTILITY(U,$J,358.3,6627,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6627,1,4,0)
 ;;=4^585.2
 ;;^UTILITY(U,$J,358.3,6627,1,5,0)
 ;;=5^CHR Kid Dis,Stage II
 ;;^UTILITY(U,$J,358.3,6627,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,6628,0)
 ;;=585.3^^43^445^3
 ;;^UTILITY(U,$J,358.3,6628,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6628,1,4,0)
 ;;=4^585.3
 ;;^UTILITY(U,$J,358.3,6628,1,5,0)
 ;;=5^CHR Kid Dis,Stage III
 ;;^UTILITY(U,$J,358.3,6628,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,6629,0)
 ;;=585.4^^43^445^4
 ;;^UTILITY(U,$J,358.3,6629,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6629,1,4,0)
 ;;=4^585.4
 ;;^UTILITY(U,$J,358.3,6629,1,5,0)
 ;;=5^CHR Kid Dis,Stage IV
 ;;^UTILITY(U,$J,358.3,6629,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,6630,0)
 ;;=585.5^^43^445^5
 ;;^UTILITY(U,$J,358.3,6630,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6630,1,4,0)
 ;;=4^585.5
 ;;^UTILITY(U,$J,358.3,6630,1,5,0)
 ;;=5^CHR Kid Dis,Stage V
 ;;^UTILITY(U,$J,358.3,6630,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,6631,0)
 ;;=V01.79^^43^446^6
 ;;^UTILITY(U,$J,358.3,6631,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6631,1,4,0)
 ;;=4^V01.79
 ;;^UTILITY(U,$J,358.3,6631,1,5,0)
 ;;=5^Viral Dis Contact
 ;;^UTILITY(U,$J,358.3,6631,2)
 ;;=^331577
 ;;^UTILITY(U,$J,358.3,6632,0)
 ;;=V01.89^^43^446^1
 ;;^UTILITY(U,$J,358.3,6632,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6632,1,4,0)
 ;;=4^V01.89
 ;;^UTILITY(U,$J,358.3,6632,1,5,0)
 ;;=5^Contact Other Comm Disease
 ;;^UTILITY(U,$J,358.3,6632,2)
 ;;=^328661
 ;;^UTILITY(U,$J,358.3,6633,0)
 ;;=V01.71^^43^446^4
 ;;^UTILITY(U,$J,358.3,6633,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6633,1,4,0)
 ;;=4^V01.71
 ;;^UTILITY(U,$J,358.3,6633,1,5,0)
 ;;=5^Varicella Contact/Exp
 ;;^UTILITY(U,$J,358.3,6633,2)
 ;;=^331576
 ;;^UTILITY(U,$J,358.3,6634,0)
 ;;=V01.79^^43^446^5
 ;;^UTILITY(U,$J,358.3,6634,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6634,1,4,0)
 ;;=4^V01.79
 ;;^UTILITY(U,$J,358.3,6634,1,5,0)
 ;;=5^Viral Dis Cont/Exp NEC
 ;;^UTILITY(U,$J,358.3,6634,2)
 ;;=^331577
 ;;^UTILITY(U,$J,358.3,6635,0)
 ;;=V01.83^^43^446^2
 ;;^UTILITY(U,$J,358.3,6635,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6635,1,4,0)
 ;;=4^V01.83
 ;;^UTILITY(U,$J,358.3,6635,1,5,0)
 ;;=5^E. Coli Contact/Exp
 ;;^UTILITY(U,$J,358.3,6635,2)
 ;;=^331578
 ;;^UTILITY(U,$J,358.3,6636,0)
 ;;=V01.84^^43^446^3
 ;;^UTILITY(U,$J,358.3,6636,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6636,1,4,0)
 ;;=4^V01.84
 ;;^UTILITY(U,$J,358.3,6636,1,5,0)
 ;;=5^Meningococcus Contact
 ;;^UTILITY(U,$J,358.3,6636,2)
 ;;=^331579
 ;;^UTILITY(U,$J,358.3,6637,0)
 ;;=250.00^^43^447^1
 ;;^UTILITY(U,$J,358.3,6637,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6637,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,6637,1,5,0)
 ;;=5^DM II w/o Complications
 ;;^UTILITY(U,$J,358.3,6637,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,6638,0)
 ;;=250.01^^43^447^2
 ;;^UTILITY(U,$J,358.3,6638,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6638,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,6638,1,5,0)
 ;;=5^DM I w/o Complications
 ;;^UTILITY(U,$J,358.3,6638,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,6639,0)
 ;;=250.40^^43^448^15
 ;;^UTILITY(U,$J,358.3,6639,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6639,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,6639,1,5,0)
 ;;=5^DM II w/Nephropathy
 ;;^UTILITY(U,$J,358.3,6639,2)
 ;;=^331795^583.81
 ;;^UTILITY(U,$J,358.3,6640,0)
 ;;=250.41^^43^448^5
 ;;^UTILITY(U,$J,358.3,6640,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6640,1,4,0)
 ;;=4^250.41
 ;;^UTILITY(U,$J,358.3,6640,1,5,0)
 ;;=5^DM I w/Nephropathy
 ;;^UTILITY(U,$J,358.3,6640,2)
 ;;=^331796^583.81
 ;;^UTILITY(U,$J,358.3,6641,0)
 ;;=250.60^^43^448^16
 ;;^UTILITY(U,$J,358.3,6641,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6641,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,6641,1,5,0)
 ;;=5^DM II w/Neuropathy
 ;;^UTILITY(U,$J,358.3,6641,2)
 ;;=^331803^357.2
 ;;^UTILITY(U,$J,358.3,6642,0)
 ;;=250.61^^43^448^6
 ;;^UTILITY(U,$J,358.3,6642,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6642,1,4,0)
 ;;=4^250.61
 ;;^UTILITY(U,$J,358.3,6642,1,5,0)
 ;;=5^DM I w/Neuropathy
 ;;^UTILITY(U,$J,358.3,6642,2)
 ;;=^331804^357.2
 ;;^UTILITY(U,$J,358.3,6643,0)
 ;;=250.70^^43^448^17
 ;;^UTILITY(U,$J,358.3,6643,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6643,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,6643,1,5,0)
 ;;=5^DM II w/PVD
 ;;^UTILITY(U,$J,358.3,6643,2)
 ;;=^331807^443.81
 ;;^UTILITY(U,$J,358.3,6644,0)
 ;;=250.71^^43^448^7
 ;;^UTILITY(U,$J,358.3,6644,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6644,1,4,0)
 ;;=4^250.71
 ;;^UTILITY(U,$J,358.3,6644,1,5,0)
 ;;=5^DM I w/PVD
 ;;^UTILITY(U,$J,358.3,6644,2)
 ;;=^331808^443.81
 ;;^UTILITY(U,$J,358.3,6645,0)
 ;;=250.80^^43^448^12
 ;;^UTILITY(U,$J,358.3,6645,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6645,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,6645,1,5,0)
 ;;=5^DM II w/L Leg Ulcer
 ;;^UTILITY(U,$J,358.3,6645,2)
 ;;=^331811^707.10
 ;;^UTILITY(U,$J,358.3,6646,0)
 ;;=250.81^^43^448^2
 ;;^UTILITY(U,$J,358.3,6646,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6646,1,4,0)
 ;;=4^250.81
 ;;^UTILITY(U,$J,358.3,6646,1,5,0)
 ;;=5^DM I w/L Leg Ulcer
 ;;^UTILITY(U,$J,358.3,6646,2)
 ;;=^331812^707.10
 ;;^UTILITY(U,$J,358.3,6647,0)
 ;;=250.50^^43^448^18
 ;;^UTILITY(U,$J,358.3,6647,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6647,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,6647,1,5,0)
 ;;=5^DM II w/Retinopathy
 ;;^UTILITY(U,$J,358.3,6647,2)
 ;;=^331799^362.01
 ;;^UTILITY(U,$J,358.3,6648,0)
 ;;=250.51^^43^448^8
 ;;^UTILITY(U,$J,358.3,6648,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6648,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,6648,1,5,0)
 ;;=5^DM I w/Retinopathy
 ;;^UTILITY(U,$J,358.3,6648,2)
 ;;=^331800^362.01
 ;;^UTILITY(U,$J,358.3,6649,0)
 ;;=250.50^^43^448^19
 ;;^UTILITY(U,$J,358.3,6649,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6649,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,6649,1,5,0)
 ;;=5^DM II w/Retinopathy NOS
 ;;^UTILITY(U,$J,358.3,6649,2)
 ;;=^331799^362.03
 ;;^UTILITY(U,$J,358.3,6650,0)
 ;;=250.51^^43^448^9
 ;;^UTILITY(U,$J,358.3,6650,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6650,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,6650,1,5,0)
 ;;=5^DM I w/Retinopathy NOS
 ;;^UTILITY(U,$J,358.3,6650,2)
 ;;=^331800^362.03
 ;;^UTILITY(U,$J,358.3,6651,0)
 ;;=250.50^^43^448^13
 ;;^UTILITY(U,$J,358.3,6651,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6651,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,6651,1,5,0)
 ;;=5^DM II w/Mild Retinopathy
 ;;^UTILITY(U,$J,358.3,6651,2)
 ;;=^331799^362.04
 ;;^UTILITY(U,$J,358.3,6652,0)
 ;;=250.51^^43^448^3
 ;;^UTILITY(U,$J,358.3,6652,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6652,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,6652,1,5,0)
 ;;=5^DM I w/Mild Retinopathy
 ;;^UTILITY(U,$J,358.3,6652,2)
 ;;=^331800^362.04
 ;;^UTILITY(U,$J,358.3,6653,0)
 ;;=250.50^^43^448^14
 ;;^UTILITY(U,$J,358.3,6653,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6653,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,6653,1,5,0)
 ;;=5^DM II w/Mod Retinopathy
 ;;^UTILITY(U,$J,358.3,6653,2)
 ;;=^331799^362.05
 ;;^UTILITY(U,$J,358.3,6654,0)
 ;;=250.51^^43^448^4
 ;;^UTILITY(U,$J,358.3,6654,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6654,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,6654,1,5,0)
 ;;=5^DM I w/Mod Retinopathy
 ;;^UTILITY(U,$J,358.3,6654,2)
 ;;=^331800^362.05
 ;;^UTILITY(U,$J,358.3,6655,0)
 ;;=250.50^^43^448^20
 ;;^UTILITY(U,$J,358.3,6655,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6655,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,6655,1,5,0)
 ;;=5^DM II w/Severe Retinopathy
 ;;^UTILITY(U,$J,358.3,6655,2)
 ;;=^331799^362.06
 ;;^UTILITY(U,$J,358.3,6656,0)
 ;;=250.51^^43^448^10
